Global Cord Blood
CORBF
$1.25
Share price
0.00%
Change (1 day)
-58.19%
Change (1 year)
Categories
Global Cord Blood (CORBF) - Net assets
Net assets on the balance sheet as of March 2022 : $0.76 B
According to Global Cord Blood's latest financial reports the company has $0.76 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Global Cord Blood - Net assets on balance sheet (from 2007 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-03-31 | $0.76 B | 15.26% |
| 2021-03-31 | $0.66 B | 21.93% |
| 2020-03-31 | $0.54 B | 7.4% |
| 2019-03-31 | $0.51 B | 2.73% |
| 2018-03-31 | $0.49 B | 85.61% |
| 2017-03-31 | $0.26 B | 0.76% |
| 2016-03-31 | $0.26 B | 6.58% |
| 2015-03-31 | $0.24 B | 7.27% |
| 2014-03-31 | $0.23 B | 16.25% |
| 2013-03-31 | $0.19 B | 1.75% |
| 2012-03-31 | $0.19 B | 17.56% |
| 2011-03-31 | $0.16 B | 38.85% |
| 2010-03-31 | $0.12 B | |
| 2008-12-31 | $20.58 M | -23.94% |
| 2007-12-31 | $27.06 M | 1.74% |
| 2006-12-31 | $26.6 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | $0.81 B | 5.67% | 🇺🇸 USA |
 National Healthcare
NHC | $0.91 B | 18.28% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.94 B | 22.32% | 🇺🇸 USA |
 Cryo-Cell CCEL | -$11.04 M | -101.43% | 🇺🇸 USA |